Vizsgálati helyszín
Southgate Medical Group, LLP
West Seneca, New York 14224, Egyesült ÁllamokMég nincs intézményhez kötve
- 8futó vizsgálat
- 14lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 22 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis19 vizsgálat
- 2. fázis3 vizsgálat
- Állapot
- Lezárult14 vizsgálat
- Még nem toboroz4 vizsgálat
- Fut, nem toboroz3 vizsgálat
- Toboroz1 vizsgálat
- Fő szponzor
- Novo Nordisk A/S22 vizsgálat
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Lezárult
A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy
NCT06797869· 2. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo
NCT06131372· 2. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
NCT06323174· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)
NCT06269107· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
NCT06221969· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
NCT06065540· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight
NCT05394519· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight
NCT05486065· 2. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec
NCT05352815· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)
NCT05259033· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)
NCT05013229· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation
NCT05021835· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
NCT03914326· 3. fázis· Novo Nordisk A/S· Forrás
Lezárult
A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease
NCT03819153· 3. fázis· Novo Nordisk A/S· Forrás
Hibát jelzek